Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations
JY Wu, SG Wu, CH Yang, YL Chang, YC Chang… - Lung cancer, 2011 - Elsevier
… population of NSCLC patients with gefitinib and erlotinib in order to … With a large proportion
of patients undergoing EGFR … all patients according to different lines of gefitinib or erlotinib. …
of patients undergoing EGFR … all patients according to different lines of gefitinib or erlotinib. …
Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis
T Yoshida, K Yamada, K Azuma, A Kawahara, H Abe… - Medical oncology, 2013 - Springer
… patients with EGFR-wt only, as gefitinib and erlotinib are well known to induce a marked
response and long PFS in patients … of the two agents directly in patients with EGFR-wt NSCLC. …
response and long PFS in patients … of the two agents directly in patients with EGFR-wt NSCLC. …
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
… (250 mg daily gefitinib or 150 mg daily erlotinib) between April … patients received gefitinib
and erlotinib treatment; therefore, we analyzed 17 plasma and 17 CSF samples from 15 patients…
and erlotinib treatment; therefore, we analyzed 17 plasma and 17 CSF samples from 15 patients…
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy
… Both gefitinib and erlotinib showed effective activity and tolerable toxicity … gefitinib and erlotinib
in an enriched patient population. … Two patients of gefitinib group and 1 patient of erlotinib …
in an enriched patient population. … Two patients of gefitinib group and 1 patient of erlotinib …
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non‑small cell lung cancer in patients with common and rare EGFR gene mutations
P Krawczyk, DM Kowalski, R Ramlau… - Oncology …, 2017 - spandidos-publications.com
… on PFS or OS in patients treated with EGFR-TKIs. Erlotinib, gefitinib, and afatinib showed …
significantly longer in patients with the exon 19 deletion compared to patients with the exon …
significantly longer in patients with the exon 19 deletion compared to patients with the exon …
[PDF][PDF] Randomized phase III study comparing gefitinib with erlotinib in patients with previously treated advanced lung adenocarcinoma: WJOG 5108L
Y Urata, N Katakami, S Morita, R Kaji… - Journal of Clinical …, 2016 - clf1.medpagetoday.com
… Previously treated patients with lung adenocarcinoma were randomly assigned … gefitinib
or erlotinib. This study aimed to investigate the noninferiority of gefitinib compared with erlotinib. …
or erlotinib. This study aimed to investigate the noninferiority of gefitinib compared with erlotinib. …
Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapy
… between gefitinib-treated and erlotinib-treated patients with NSCLC who had failed prior
chemotherapy. Our analysis shows that gefitinib and erlotinib in pretreated patients with …
chemotherapy. Our analysis shows that gefitinib and erlotinib in pretreated patients with …
Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor …
… of EGFR-TKIs in this patient population. Herein, we conducted a retrospective study to
assess the efficacy of gefitinib/erlotinib and afatinib in patients with advanced-stage lung …
assess the efficacy of gefitinib/erlotinib and afatinib in patients with advanced-stage lung …
[HTML][HTML] Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
YY Shao, WY Shau, ZZ Lin, HM Chen, R Kuo… - European Journal of …, 2013 - Elsevier
… For patients who received gefitinib or erlotinib for more than … Patients who used either
gefitinib or erlotinib as second-line … gefitinib or erlotinib as second-line therapy because erlotinib …
gefitinib or erlotinib as second-line … gefitinib or erlotinib as second-line therapy because erlotinib …
[PDF][PDF] Efficacy of gefitinib or erlotinib in patients with squamous cell lung cancer
Z Song, Y Zhang - Archives of Medical Science, 2015 - termedia.pl
… In 74 patients with adequate specimens for molecular analysis, 4 (5.4%) had EGFR … of
advanced squamous cell lung cancer patients. Erlotinib and gefitinib had a similar efficacy in …
advanced squamous cell lung cancer patients. Erlotinib and gefitinib had a similar efficacy in …
相关搜索
- efficacy of gefitinib erlotinib in patients
- cell lung cancer erlotinib in patients
- comparison of gefitinib and erlotinib
- lung adenocarcinoma erlotinib in patients
- gefitinib erlotinib and afatinib
- gefitinib or erlotinib somatic egfr mutations
- randomized clinical trials gefitinib and erlotinib
- gefitinib or erlotinib cohort study
- gefitinib or erlotinib clinical course
- previous chemotherapy erlotinib in patients
- randomized phase erlotinib in patients
- study of gefitinib erlotinib in patients
- gefitinib treatment erlotinib in patients
- cerebrospinal fluid concentration gefitinib and erlotinib
- lung adenosquamous carcinoma gefitinib and erlotinib
- gefitinib or erlotinib system metastases